September 2, 2024
The brain needs a lot of energy 鈥 far more than any other organ in the body 鈥 to work properly. And aging and Alzheimer鈥檚 disease both seem to leave the brain underpowered.
But an experimental cancer drug appeared to re-energize the brains of mice that had a form of Alzheimer鈥檚 鈥 and even restore their ability to learn and remember.
The finding, in the journal Science, suggests that it may eventually be possible to reverse some symptoms of Alzheimer鈥檚 in people, using drugs that boost brain metabolism.
The results also offer an approach to treatment that鈥檚 unlike anything on the market today. Current drugs for treating Alzheimer鈥檚, such as lecanemab and donanemab, target the sticky amyloid plaques that build up in a patient鈥檚 brain. These drugs can remove plaques and slow the disease process, but do not improve memory or thinking.
The result should help 鈥渃hange how we think about targeting this disease,鈥 says Shannon Macauley, an associate professor at the University of Kentucky who was not involved in the study.
A surprise, then a discovery
The new research was prompted by a lab experiment that didn鈥檛 go as planned.
A team at Stanford was studying an enzyme called IDO1 that plays a key role in keeping a cell鈥檚 metabolism running properly. They suspected that in Alzheimer鈥檚 disease, IDO1 was malfunctioning in a way that limited the brain鈥檚 ability to turn nutrients into energy.
So the team used genetics to eliminate the enzyme entirely from mice that develop a form of Alzheimer鈥檚. They figured that without any IDO1, brain metabolism would decline.
鈥淲e expected to see everything [get] much, much, much worse鈥, says , a professor of neurology and neuroscience at Stanford. 鈥淏ut no, it was the complete opposite.鈥
Without the enzyme, the mouse brains were actually better at turning glucose into energy and didn鈥檛 exhibit the memory loss usually associated with Alzheimer鈥檚.
鈥淚t was such a profound rescue that we sort of went back to the drawing board and tried to figure out what was going on,鈥 Andreasson says.
Eventually, the team found an explanation.
Getting rid of the enzyme had altered the behavior of cells called astrocytes.
Usually, astrocytes help provide energy to neurons, the cells that allow for learning and memory. But when the toxic plaques and tangles of Alzheimer鈥檚 begin to appear in the brain, levels of IDO1 rise and astrocytes stop doing this job.
鈥淭hey鈥檙e kind of put to sleep,鈥 Andreasson says. So 鈥測ou鈥檝e got to wake them up to get them to help the neurons.鈥
And that鈥檚 what happened when scientists used genetics to remove IDO1.
Their hypothesis was that high levels of IDO1 were limiting the astrocytes鈥 ability to produce lactate, a chemical that helps brain cells, including neurons, transform food into energy.
To confirm the hypothesis, the team, led by , did a series of experiments. One involved placing a mouse in the center of a shiny white disk under a bright light.
鈥淚t really wants to get out of there,鈥 Andreasson says. 鈥淏ut it has to learn where the escape hole is鈥 by following visual cues.
Healthy mice learned how to read those cues after a few days of training, and would escape almost instantly.
鈥淏ut in the Alzheimer mice, the time to find the escape hole really skyrocketed,鈥 Andreasson says.
That changed when the team gave these mice an experimental cancer drug that could block the enzyme much the way genetic engineering had.
The treated mice learned to escape the bright light as quickly as healthy animals. And a look at their brains showed that their astrocytes had woken up and were helping neurons produce the energy needed for memory and thinking.
In the hippocampus, a brain area that鈥檚 critical for memory and navigation, tests showed that the drug had restored normal glucose metabolism even though the plaques and tangles of Alzheimer鈥檚 were still present.
The team also tested human astrocytes and neurons derived from Alzheimer鈥檚 patients. And once again, the drug restored normal function.
Beyond plaques and tangles
The experiments add to the evidence that Alzheimer鈥檚 involves a lot more than just the appearance of plaques and tangles.
鈥淲e can have these metabolic changes in our brain,鈥 Macaulay says, 鈥渂ut they鈥檙e reversible.鈥
Neurons have long been the focus of Alzheimer鈥檚 research. But the new results also show how other kinds of cells in the brain can play an important role in the disease.
The brain is a bit like a beehive, where a neuron is the queen, Macaulay says. But she鈥檚 kept alive by worker bees, like astrocytes, which are asked to do more as Alzheimer鈥檚 changes the brain.
鈥淭hose worker bees are getting unbelievably taxed from all the things they are being asked to do,鈥 Macaulay says. 鈥淲hen that happens, then the whole system doesn鈥檛 work well.鈥
Metabolic treatments that restore astrocytes and other helper cells in the brain could someday augment existing Alzheimer鈥檚 drugs that remove amyloid plaques, Macauley says.
And the metabolic approach may be able to improve memory and thinking 鈥 something amyloid drugs don鈥檛 do.
鈥淢aybe this can make your astrocytes and your neurons work a little bit better, so that you function a little bit better,鈥 Macaulay says.
But first, she says, the promising results will have to be replicated in people.
Listen to the story .